XML 168 R64.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
FAIR VALUE MEASUREMENTS (Tables)
12 Months Ended
Nov. 03, 2019
FAIR VALUE MEASUREMENTS  
Fair Value of Financial Instruments

The fair values of financial instruments that do not approximate the carrying values at November 3, 2019 and October 28, 2018 in millions of dollars follow:

2019

2018

Carrying

     Fair     

Carrying

     Fair     

  

Value

  

Value*

  

Value

  

Value*

 

Financing receivables – net:

 

 

 

 

Equipment operations

$

65

$

61

$

93

$

91

Financial services

29,130

29,106

26,961

26,722

Total

$

29,195

$

29,167

$

27,054

$

26,813

Financing receivables securitized – net:

 

 

 

 

Equipment operations

$

44

$

43

$

76

$

73

Financial services

4,339

4,362

3,946

3,895

Total

$

4,383

$

4,405

$

4,022

$

3,968

Short-term securitization borrowings:

 

 

 

 

Equipment operations

$

44

$

45

$

75

$

75

Financial services

4,277

4,302

3,882

3,870

Total

$

4,321

$

4,347

$

3,957

$

3,945

Long-term borrowings due within one year:

Equipment operations

 

$

642

 

$

645

 

$

970

 

$

979

Financial services

 

6,786

 

6,788

 

5,427

 

5,411

Total

 

$

7,428

 

$

7,433

 

$

6,397

 

$

6,390

Long-term borrowings:

Equipment operations

 

$

5,415

 

$

6,138

 

$

4,714

 

$

4,948

Financial services

 

24,814

 

25,122

 

22,523

 

22,590

Total

 

$

30,229

 

$

31,260

 

$

27,237

 

$

27,538

*    Fair value measurements above were Level 3 for all financing receivables, Level 3 for equipment operations short-term securitization borrowings, and Level 2 for all other borrowings.

Assets and Liabilities Measured at Fair Value on a Recurring Basis

Assets and liabilities measured at November 3, 2019 and October 28, 2018 at fair value on a recurring basis in millions of dollars follow*:

    

   2019   

    

   2018   

  

Level 1:

Marketable securities

Equity fund

 

$

59

 

$

46

U.S. government debt securities

 

50

 

44

Total Level 1 marketable securities

109

90

Level 2:

Marketable securities

U.S. government debt securities

81

67

Municipal debt securities

 

60

 

46

Corporate debt securities

 

165

 

140

International debt securities

5

2

Mortgage-backed securities**

 

160

 

137

Total Level 2 marketable securities

 

471

 

392

Other assets

Derivatives:

Interest rate contracts

 

363

 

80

Foreign exchange contracts

 

20

 

83

Cross-currency interest rate contracts

 

1

 

5

Total Level 2 other assets

384

168

Accounts payable and accrued expenses

Derivatives:

Interest rate contracts

 

65

 

350

Foreign exchange contracts

 

71

 

49

Cross-currency interest rate contracts

3

 

Total Level 2 accounts payable and accrued expenses

139

399

Level 3:

Marketable securities

International debt securities

 

1

 

8

*      Excluded from this table were the company’s cash equivalents, which were carried at cost that approximates fair value. The cash equivalents consist primarily of money market funds and time deposits.

**    Primarily issued by U.S. government sponsored enterprises.

Fair Value, Recurring, Level 3 Measurements

Fair value, recurring Level 3 measurements from available-for-sale marketable securities at November 3, 2019, October 28, 2018, and October 29, 2017 in millions of dollars follow:

    

    2019    

    

    2018    

    

    2017    

Beginning of year balance

$

8

$

17

 

$

28

Principal payments

(8)

(9)

(13)

Change in unrealized gain

1

2

Other

1

(1)

End of year balance

$

1

$

8

$

17

Fair Value, Nonrecurring Measurements From Impairments

Fair value, nonrecurring measurements from impairments at November 3, 2019 and October 28, 2018 in millions of dollars follow:

Fair Value*

Losses*

  

 2019 

  

 2018 

  

 2019 

  

 2018 

  

 2017 

Equipment on operating leases – net

 

$

855

 

 

$

59

 

Investments in
unconsolidated affiliates

 

$

40

Other assets

 

$

142

 

$

18

*    Fair value losses at October 29, 2017 were a Level 1 measurement. See financing receivables with specific allowances in Note 13 that were not significant. See Note 5 for impairments.